CN118453215A - Ascending aorta external support - Google Patents
Ascending aorta external support Download PDFInfo
- Publication number
- CN118453215A CN118453215A CN202410752795.5A CN202410752795A CN118453215A CN 118453215 A CN118453215 A CN 118453215A CN 202410752795 A CN202410752795 A CN 202410752795A CN 118453215 A CN118453215 A CN 118453215A
- Authority
- CN
- China
- Prior art keywords
- membrane
- ascending aorta
- external stent
- branch
- diaphragm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000709 aorta Anatomy 0.000 title claims abstract description 117
- 210000001367 artery Anatomy 0.000 claims abstract description 10
- 239000000725 suspension Substances 0.000 claims abstract description 10
- 239000012528 membrane Substances 0.000 claims description 126
- 210000002376 aorta thoracic Anatomy 0.000 claims description 10
- 230000037303 wrinkles Effects 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 claims description 6
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 claims description 6
- 230000001174 ascending effect Effects 0.000 abstract description 15
- 208000007474 aortic aneurysm Diseases 0.000 abstract description 13
- 239000012530 fluid Substances 0.000 abstract description 5
- 206010018852 Haematoma Diseases 0.000 abstract description 4
- 238000002224 dissection Methods 0.000 abstract description 4
- 230000001681 protective effect Effects 0.000 abstract description 4
- 230000002250 progressing effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 description 15
- 210000004204 blood vessel Anatomy 0.000 description 12
- 239000002473 artificial blood Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 238000001356 surgical procedure Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000001765 aortic valve Anatomy 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 201000002064 aortic valve insufficiency Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 230000008733 trauma Effects 0.000 description 5
- 238000007493 shaping process Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 210000003291 sinus of valsalva Anatomy 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 101001121408 Homo sapiens L-amino-acid oxidase Proteins 0.000 description 2
- 102100026388 L-amino-acid oxidase Human genes 0.000 description 2
- 101100012902 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) FIG2 gene Proteins 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 238000007157 ring contraction reaction Methods 0.000 description 2
- 210000005239 tubule Anatomy 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- 206010002329 Aneurysm Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000009137 Behcet syndrome Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- 208000007465 Giant cell arteritis Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 208000001826 Marfan syndrome Diseases 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 208000006379 syphilis Diseases 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
本发明公开了一种升主动脉外支架,包括外支架膜片和分支膜片,外支架膜片可收卷形成环状包裹结构并包裹在升主动脉的外侧,环状包裹结构的一端延伸至窦管交界处,环状包裹结构的另一端延伸至靠近分支动脉的位置;分支膜片的端部与外支架膜片相连,分支膜片上设有悬吊部。本发明通过外支架膜片对扩张的升主动脉进行整体包裹,一方面通过塑性,使扩张的升主动脉恢复正常的形态,恢复良好的流体力学特征;另一方面通过包裹,消除了升主动脉瘤进展至破裂、夹层和壁间血肿的风险。此外,分支膜片的设计能够防止外支架膜片在升主动脉上发生移位,使得外支架膜片对于升主动脉的远端能够起到很好的保护与支持作用。
The present invention discloses an ascending aorta external stent, including an external stent diaphragm and a branch diaphragm. The external stent diaphragm can be rolled up to form an annular wrapping structure and wrapped around the outside of the ascending aorta. One end of the annular wrapping structure extends to the junction of the sinus and tube, and the other end of the annular wrapping structure extends to a position close to the branch artery. The end of the branch diaphragm is connected to the external stent diaphragm, and a suspension portion is provided on the branch diaphragm. The present invention wraps the dilated ascending aorta as a whole through the external stent diaphragm. On the one hand, through plasticity, the dilated ascending aorta is restored to a normal shape and good fluid mechanics characteristics; on the other hand, through wrapping, the risk of the ascending aortic aneurysm progressing to rupture, dissection and intramural hematoma is eliminated. In addition, the design of the branch diaphragm can prevent the external stent diaphragm from shifting on the ascending aorta, so that the external stent diaphragm can play a good protective and supporting role for the distal end of the ascending aorta.
Description
技术领域Technical Field
本发明属于医疗器械技术领域,具体涉及一种升主动脉外支架。The invention belongs to the technical field of medical devices, and in particular relates to an ascending aorta external stent.
背景技术Background Art
升主动脉瘤是指局部升主动脉壁扩张或膨出,其直径显著大于正常值,扩张的升主动脉具有发生夹层和壁间血肿、破裂等风险,严重危害生命健康。升主动脉瘤的原因有:动脉粥样硬化,为最常见的原因;感染,以梅毒为显著;囊性中层坏死,主要见于升主动脉瘤,男性较多见。遗传性疾病如马凡综合征等均可有囊性中层坏死,易致夹层动脉瘤;先天因素,包括巨细胞性主动脉炎、白塞氏病、多发性大动脉炎等。Ascending aortic aneurysm refers to the expansion or bulging of the local ascending aortic wall, and its diameter is significantly larger than the normal value. The dilated ascending aorta has the risk of dissection, intramural hematoma, rupture, etc., which seriously endangers life and health. The causes of ascending aortic aneurysm are: atherosclerosis, which is the most common cause; infection, with syphilis being the most prominent; cystic medial necrosis, which is mainly seen in ascending aortic aneurysm, and is more common in men. Genetic diseases such as Marfan syndrome can cause cystic medial necrosis, which is prone to dissecting aneurysms; congenital factors, including giant cell aortitis, Behcet's disease, and polyarteritis.
对于升主动脉瘤,现有的治疗手段如下:The current treatment options for ascending aortic aneurysms are as follows:
(1)升主动脉置换术,该技术将扩张的升主动脉切除掉,并使用商品化的人工血管进行替代。其存在的缺陷有:(a)由于需要将人体最粗的动脉切除掉,再将人工血管缝合上去,且需要在手术中使用体外循环技术,阻断升主动脉,手术的难度和创伤相对较大,出血的风险高,术后恢复时间相对较长;(b)对于升主动脉远端至主动脉弓近端仍存在扩张的情况,若采取单纯升主动脉置换的方法,容易造成人工血管与远端自身主动脉的直径不匹配,在远端吻合口处形成极不自然的血管形态,影响流体力学,出现后续进展情况;若采取将扩张的升主动脉远端及部分主动脉弓切除并置换的手术方式,则需要用到停止体外循环、脑保护等复杂技术,进一步增加手术难度与创伤。(1) Ascending aorta replacement, this technique removes the dilated ascending aorta and replaces it with a commercial artificial blood vessel. Its defects include: (a) Since the thickest artery in the human body needs to be removed and then the artificial blood vessel is sutured, and the extracorporeal circulation technology needs to be used during the operation to block the ascending aorta, the difficulty and trauma of the operation are relatively large, the risk of bleeding is high, and the postoperative recovery time is relatively long; (b) If the ascending aorta is still dilated from the distal end to the proximal end of the aortic arch, if a simple ascending aorta replacement method is adopted, it is easy to cause the diameter of the artificial blood vessel to be mismatched with the distal aorta, forming an extremely unnatural vascular morphology at the distal anastomosis, affecting fluid mechanics and causing subsequent progression; if the surgical method of removing and replacing the dilated distal ascending aorta and part of the aortic arch is adopted, complex techniques such as stopping extracorporeal circulation and brain protection are required, which further increases the difficulty and trauma of the operation.
(2)基于切缝技术的升主动脉成型术,该技术将扩张的升主动脉纵行切开,纵行切除掉部分升主动脉管壁组织(或不切除),再进行缝合,通过缝合时的进出针位置及缝合方法,将升主动脉进行一定程度的缩窄。其存在的缺陷有:(a)该技术同样需要使用体外循环技术,阻断升主动脉,手术难度及创伤相对较大,出血风险高;(b)切缝技术对升主动脉的塑性效果不佳,成型后的升主动脉形态极不自然,同时还破坏了主动脉壁组织,对流体力学及组织生理学均有负面影响;(c)切缝技术无法有效阻止升主动脉在后期的进一步扩张,存在后期进展风险,远期效果不佳。(2) Ascending aorta plasty based on suture technology, this technology longitudinally cuts the dilated ascending aorta, removes part of the ascending aorta wall tissue longitudinally (or does not remove it), and then sutures it. The ascending aorta is narrowed to a certain extent by the position of the needle in and out and the suture method during suturing. Its defects are: (a) This technology also requires the use of extracorporeal circulation technology to block the ascending aorta, which is relatively difficult and traumatic, and has a high risk of bleeding; (b) The suture technology has a poor plastic effect on the ascending aorta. The shape of the ascending aorta after shaping is extremely unnatural. At the same time, it also destroys the aortic wall tissue, which has a negative impact on fluid mechanics and tissue physiology; (c) The suture technology cannot effectively prevent the further expansion of the ascending aorta in the later stage, there is a risk of late progression, and the long-term effect is not good.
(3)基于人工血管自制材料的升主动脉包裹技术,该技术将人工血管纵行剪开,裁剪至合适尺寸,制作成人工血管片,并将该人工血管片包裹在扩张的升主动脉周围,将其进行缩窄和塑形,消除升主动脉瘤远期进展的风险。升主动脉包裹技术与传统开放手术相比,免去了对升主动脉的切除、切开等操作,完整保留了自身的升主动脉,极大程度地降低了手术难度、手术创伤及风险。但是现有的升主动脉包裹技术不太成熟,其存在的缺陷有:(a)目前尚无专门用于包裹升主动脉的产品,采用该方法时,所使用的包裹片均为将人工血管裁剪后所得;但人工血管本身是用于动脉置换手术的,而非用于包裹,因此其形态、材质及尺寸大小上并不适合于升主动脉包裹技术;过硬的人工血管片材质可能会对自身的主动脉管壁组织造成一定程度的压迫损伤;当自身的升主动脉较长时,现有最大型号的人工血管在裁剪后亦有可能无法满足包裹片所需尺寸;(b)目前的包裹技术仅对升主动脉进行包裹,对包裹段的远近两端无特殊处理,在术后随访时发现,包裹片近远两端的自身升主动脉因无包裹片限制而容易出现扩张,升主动脉整体呈现“哑铃样”形态;另外,这样的包裹片在升主动脉上容易纵向移位,影响包裹效果。(3) Ascending aorta wrapping technology based on artificial blood vessel homemade materials, this technology cuts the artificial blood vessel longitudinally, cuts it to the appropriate size, makes an artificial blood vessel sheet, and wraps the artificial blood vessel sheet around the dilated ascending aorta to narrow and shape it, eliminating the risk of long-term progression of ascending aortic aneurysm. Compared with traditional open surgery, the ascending aorta wrapping technology avoids the need for resection and incision of the ascending aorta, completely preserves the ascending aorta, and greatly reduces the difficulty, trauma and risk of surgery. However, the existing ascending aorta wrapping technology is not very mature, and its defects include: (a) There is currently no product specifically used for wrapping the ascending aorta. When this method is used, the wrapping sheets used are all obtained by cutting artificial blood vessels; but artificial blood vessels themselves are used for arterial replacement surgery, not for wrapping, so their shape, material and size are not suitable for ascending aorta wrapping technology; artificial blood vessel sheets that are too hard may cause a certain degree of compression and damage to the aortic wall tissue of the body; when the body's ascending aorta is long, the largest existing artificial blood vessel may not meet the required size of the wrapping sheet after cutting; (b) The current wrapping technology only wraps the ascending aorta, and there is no special treatment for the proximal and distal ends of the wrapping segment. During postoperative follow-up, it was found that the native ascending aorta at the proximal and distal ends of the wrapping sheet was prone to expansion due to the lack of wrapping sheet restrictions, and the ascending aorta as a whole showed a "dumbbell-like" shape; in addition, such a wrapping sheet is prone to longitudinal displacement on the ascending aorta, affecting the wrapping effect.
发明内容Summary of the invention
本发明的目的是提供一种升主动脉外支架,用于解决现有技术中存在的上述问题。The purpose of the present invention is to provide an ascending aorta external stent to solve the above-mentioned problems existing in the prior art.
为了实现上述目的,本发明采用以下技术方案:一种升主动脉外支架,包括外支架膜片和分支膜片,所述外支架膜片可收卷形成环状包裹结构并包裹在升主动脉的外侧,所述环状包裹结构与升主动脉的外壁贴合,以对升主动脉进行塑形;所述环状包裹结构的一端延伸至窦管交界处,环状包裹结构的另一端延伸至靠近主动脉弓的位置;所述分支膜片的端部与外支架膜片相连,分支膜片上设有悬吊部,所述悬吊部套设在分支动脉上并对主动脉弓进行部分包裹。In order to achieve the above-mentioned purpose, the present invention adopts the following technical scheme: an ascending aorta external stent, including an external stent membrane and a branch membrane, the external stent membrane can be rolled up to form an annular wrapping structure and wrapped around the outside of the ascending aorta, the annular wrapping structure fits the outer wall of the ascending aorta to shape the ascending aorta; one end of the annular wrapping structure extends to the junction of the sinus tube, and the other end of the annular wrapping structure extends to a position close to the aortic arch; the end of the branch membrane is connected to the external stent membrane, and a suspension part is provided on the branch membrane, and the suspension part is mounted on the branch artery and partially wraps the aortic arch.
作为上述技术方案的一种可选实施方式,所述外支架膜片包括第一膜体和第二膜体,所述第一膜体和第二膜体相互靠近的一侧相连,且第一膜体和第二膜体之间设有上缺口部和下缺口部,所述上缺口部和下缺口部均位于升主动脉的外壁内侧,以避免环状包裹结构出现局部褶皱。As an optional implementation of the above technical solution, the external support membrane includes a first membrane body and a second membrane body, the first membrane body and the second membrane body are connected on one side close to each other, and an upper notch portion and a lower notch portion are provided between the first membrane body and the second membrane body, and the upper notch portion and the lower notch portion are both located on the inner side of the outer wall of the ascending aorta to avoid local wrinkles in the annular wrapping structure.
作为上述技术方案的一种可选实施方式,所述第一膜体和第二膜体相互远离的一侧均设有圆弧边,所述圆弧边的弯曲弧度与升主动脉的外壁外侧弯曲弧度匹配。As an optional implementation of the above technical solution, the first membrane body and the second membrane body are both provided with arc edges on the sides away from each other, and the curvature of the arc edges matches the curvature of the outer side of the outer wall of the ascending aorta.
作为上述技术方案的一种可选实施方式,所述第一膜体和第二膜体一体成型。As an optional implementation of the above technical solution, the first film body and the second film body are integrally formed.
作为上述技术方案的一种可选实施方式,所述第一膜体的圆弧边设有第一缝合带,第二膜体的圆弧边设有第二缝合带,所述第一缝合带和第二缝合带相互缝合,以使第一膜体和第二膜体形成所述环状包裹结构。As an optional implementation of the above technical solution, the arc edge of the first membrane body is provided with a first suture belt, and the arc edge of the second membrane body is provided with a second suture belt. The first suture belt and the second suture belt are sutured to each other so that the first membrane body and the second membrane body form the annular wrapping structure.
作为上述技术方案的一种可选实施方式,所述环状包裹结构与窦管交界处之间设有若干垫片。As an optional implementation of the above technical solution, a plurality of gaskets are provided between the annular wrapping structure and the junction of the sinus tube.
作为上述技术方案的一种可选实施方式,所述环状包裹结构与窦管交界处之间设有多个垫片,多个垫片呈环状分布,且多个垫片均通过缝合固定在外支架膜片上。As an optional implementation of the above technical solution, a plurality of gaskets are provided between the annular wrapping structure and the junction of the sinus tube, the plurality of gaskets are distributed in an annular shape, and the plurality of gaskets are fixed on the outer support membrane by suturing.
作为上述技术方案的一种可选实施方式,所述外支架膜片的底部设有下缝合带,所述垫片与下缝合带连接。As an optional implementation of the above technical solution, a lower suture belt is provided at the bottom of the outer support membrane, and the gasket is connected to the lower suture belt.
作为上述技术方案的一种可选实施方式,所述外支架膜片和分支膜片均采用超高分子量聚乙烯材料制成,外支架膜片和分支膜片表面均设有网孔结构。As an optional implementation of the above technical solution, the outer support membrane and the branch membrane are both made of ultra-high molecular weight polyethylene material, and the surfaces of the outer support membrane and the branch membrane are both provided with mesh structures.
作为上述技术方案的一种可选实施方式,所述分支膜片的两端均与外支架膜片缝合连接。As an optional implementation of the above technical solution, both ends of the branch membrane are sutured and connected to the outer support membrane.
作为上述技术方案的一种可选实施方式,所述外支架膜片的顶部设有上缝合带,分支膜片的两端均与上缝合带连接。As an optional implementation of the above technical solution, an upper suture band is provided on the top of the outer support membrane, and both ends of the branch membrane are connected to the upper suture band.
本发明的有益效果为:The beneficial effects of the present invention are:
本发明提供的升主动脉外支架用于外科手术治疗升主动脉瘤,通过外支架膜片对扩张的升主动脉进行整体包裹,一方面通过塑性,使扩张的升主动脉恢复正常的形态,恢复良好的流体力学特征;另一方面通过包裹,消除了升主动脉瘤进展至破裂、夹层和壁间血肿的风险。此外,分支膜片的设计能够防止外支架膜片在升主动脉上发生移位,使得外支架膜片对于升主动脉的远端能够起到很好的保护与支持作用。The ascending aorta external stent provided by the present invention is used for surgical treatment of ascending aortic aneurysm. The expanded ascending aorta is wrapped as a whole by the external stent membrane. On the one hand, the expanded ascending aorta is restored to a normal shape and good fluid mechanics characteristics through plasticity; on the other hand, the risk of the ascending aortic aneurysm progressing to rupture, dissection and intramural hematoma is eliminated through wrapping. In addition, the design of the branch membrane can prevent the external stent membrane from shifting on the ascending aorta, so that the external stent membrane can play a good role in protecting and supporting the distal end of the ascending aorta.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是本发明一种实施方式中升主动脉外支架的使用状态图;FIG1 is a diagram showing a state of use of an ascending aorta external stent in one embodiment of the present invention;
图2是本发明一种实施方式中外支架膜片和分支膜片的结构示意图。FIG. 2 is a schematic diagram of the structure of an outer support membrane and a branch membrane in one embodiment of the present invention.
图中:1-外支架膜片;2-分支膜片;3-升主动脉;4-分支动脉;5-第一膜体;6-第二膜体;7-上缺口部;8-下缺口部;9-第一缝合带;10-第二缝合带;11-垫片;12-下缝合带;13-上缝合带。In the figure: 1-external stent membrane; 2-branch membrane; 3-ascending aorta; 4-branch artery; 5-first membrane body; 6-second membrane body; 7-upper notch; 8-lower notch; 9-first suture band; 10-second suture band; 11-gasket; 12-lower suture band; 13-upper suture band.
具体实施方式DETAILED DESCRIPTION
如图1和图2所示,本实施例提供了一种升主动脉外支架,包括外支架膜片1和分支膜片2,外支架膜片1呈长片状,所述外支架膜片1可收卷形成环状包裹结构并包裹在升主动脉3的外侧,所述环状包裹结构与升主动脉3的外壁贴合,以对升主动脉3进行塑形,消除了升主动脉瘤远期进展的风险。所述环状包裹结构的一端延伸至窦管交界处,环状包裹结构的另一端延伸至靠近主动脉弓的位置。外支架膜片1通过对升主动脉3进行整体包裹,避免升主动脉3近远两端因无包裹限制而容易出现扩张的问题,防止升主动脉3两端进一步扩张整体呈现“哑铃样”形态。As shown in Figures 1 and 2, this embodiment provides an ascending aorta external stent, including an external stent membrane 1 and a branch membrane 2. The external stent membrane 1 is in the shape of a long sheet. The external stent membrane 1 can be rolled up to form an annular wrapping structure and wrapped around the outside of the ascending aorta 3. The annular wrapping structure fits the outer wall of the ascending aorta 3 to shape the ascending aorta 3, eliminating the risk of long-term progression of ascending aortic aneurysm. One end of the annular wrapping structure extends to the junction of the sinus tube, and the other end of the annular wrapping structure extends to a position close to the aortic arch. The external stent membrane 1 wraps the ascending aorta 3 as a whole, avoiding the problem of expansion at the proximal and distal ends of the ascending aorta 3 due to the lack of wrapping restrictions, and preventing the two ends of the ascending aorta 3 from further expanding and presenting a "dumbbell-like" shape as a whole.
如图2所示,分支膜片2呈长条状,所述分支膜片2的端部与外支架膜片1相连,分支膜片2上设有悬吊部,所述悬吊部套设在分支动脉4上并对主动脉弓进行部分包裹。悬吊部挂在分支动脉4上,防止外支架膜片1在升主动脉3上产生纵向移位。As shown in FIG2 , the branch diaphragm 2 is in the shape of a long strip, and the end of the branch diaphragm 2 is connected to the external stent diaphragm 1. A suspension portion is provided on the branch diaphragm 2, and the suspension portion is sleeved on the branch artery 4 and partially wraps the aortic arch. The suspension portion is hung on the branch artery 4 to prevent the external stent diaphragm 1 from longitudinally shifting on the ascending aorta 3.
本发明提供的升主动脉外支架用于外科手术治疗升主动脉瘤,通过外支架膜片1对扩张的升主动脉3进行整体包裹,一方面通过塑性,使扩张的升主动脉3恢复正常的形态,恢复良好的流体力学特征;另一方面通过包裹,消除了升主动脉瘤进展至破裂、夹层和壁间血肿的风险。此外,分支膜片2的设计能够防止外支架膜片1在升主动脉3上发生移位,使得外支架膜片1对于升主动脉3的远端能够起到很好的保护与支持作用。The ascending aorta external stent provided by the present invention is used for surgical treatment of ascending aortic aneurysms. The expanded ascending aorta 3 is wrapped as a whole by the external stent membrane 1. On the one hand, the expanded ascending aorta 3 is restored to a normal shape and good fluid mechanics characteristics through plasticity; on the other hand, the risk of the ascending aortic aneurysm progressing to rupture, dissection and intramural hematoma is eliminated through wrapping. In addition, the design of the branch membrane 2 can prevent the external stent membrane 1 from shifting on the ascending aorta 3, so that the external stent membrane 1 can play a good role in protecting and supporting the distal end of the ascending aorta 3.
本发明的升主动脉外支架,并非单纯包裹升主动脉3,环状包裹结构向上通过分支膜片2加固悬吊,向下延伸至窦管交界处,这样一种整体性包裹理念能够很好的优化包裹后的远期效果,避免远期在上下两端出现疾病进展(通常进展发生的部位);此外,外支架膜片1的下端至少达到了窦管交界处的位置,甚至超越,这样的包裹实质上对主动脉窦和其内的主动脉瓣环起到了一定的固定和环缩作用,会对主动脉瓣环起到轻到中度的成型效果;而升主动脉瘤常会合并主动脉根部瘤,且出现主动脉瓣反流的情况,这样一种整体性包裹的理念实质上在一定程度上会减轻主动脉瓣反流的程度,达到减轻主动脉瓣反流的作用。而这一效果的基础就是整体性包裹,现有技术没有整体性包裹的理念,在实际包裹中往往不会向下达到窦管交界处,因为手术越往下游离,周围的重要组织结构越多,手术难度越大,因此可以认为只有具有整体性包裹的理念,才能使得升主动脉外支架具有潜在的减轻主动脉瓣反流的作用。The ascending aorta external stent of the present invention does not simply wrap the ascending aorta 3. The annular wrapping structure is reinforced and suspended upward by the branch membrane 2 and extends downward to the junction of the sinus and tubule. Such an overall wrapping concept can well optimize the long-term effect after wrapping and avoid the long-term disease progression at the upper and lower ends (the site where progression usually occurs); in addition, the lower end of the external stent membrane 1 at least reaches the position of the junction of the sinus and tubule, or even exceeds it. Such wrapping actually has a certain fixing and ring contraction effect on the aortic sinus and the aortic valve ring therein, and will have a mild to moderate molding effect on the aortic valve ring; and ascending aortic aneurysms are often combined with aortic root aneurysms and aortic valve regurgitation. Such an overall wrapping concept will actually reduce the degree of aortic valve regurgitation to a certain extent, thereby achieving the effect of reducing aortic valve regurgitation. The basis of this effect is holistic wrapping. The existing technology does not have the concept of holistic wrapping, and in actual wrapping it often does not reach down to the sinotubular junction. This is because the further downstream the surgery is, the more important tissue structures there are around it, and the more difficult the surgery becomes. Therefore, it can be considered that only with the concept of holistic wrapping can the ascending aortic stent have the potential to reduce aortic valve regurgitation.
需要说明的是,本发明的外支架膜片1根据患者升主动脉3的尺寸进行个体定制化,针对不同患者的升主动脉3自身的形态特点,使得外支架膜片1在包裹时能够与升主动脉3外壁很好的贴合,从而实现整体性定制化的包裹。It should be noted that the external stent membrane 1 of the present invention is individually customized according to the size of the patient's ascending aorta 3, and based on the morphological characteristics of the ascending aorta 3 of different patients, the external stent membrane 1 can fit well with the outer wall of the ascending aorta 3 when wrapped, thereby achieving overall customized wrapping.
如图2所示,在本实施例中,所述外支架膜片1包括第一膜体5和第二膜体6,第一膜体5和第二膜体6的结构相同,所述第一膜体5和第二膜体6相互靠近的一侧相连,且第一膜体5和第二膜体6之间设有上缺口部7和下缺口部8,所述上缺口部7和下缺口部8均位于升主动脉3的外壁内侧,以避免环状包裹结构出现局部褶皱。优选地,所述第一膜体5和第二膜体6采用3D打印一体成型。由于升主动脉3具有特殊形态,外支架膜片1包裹升主动脉3时容易出现局部褶皱,若出现局部褶皱,会对主动脉壁产生压迫,影响主动脉壁组织,容易造成了物理损伤、压迫缺血等问题。本发明的外支架膜片1并非矩形片状,而是由相同结构的第一膜体5和第二膜体6组成,且第一膜体5和第二膜体6之间具有上缺口部7和下缺口部8,上缺口部7和下缺口部8均位于升主动脉3的外壁内侧,这样包裹起来才能很好地符合升主动脉3的形态,并能很好地与升主动脉3贴合,避免环状包裹结构出现局部褶皱的情况。As shown in FIG2 , in this embodiment, the external support membrane 1 includes a first membrane body 5 and a second membrane body 6, the first membrane body 5 and the second membrane body 6 have the same structure, the first membrane body 5 and the second membrane body 6 are connected on one side close to each other, and an upper notch 7 and a lower notch 8 are provided between the first membrane body 5 and the second membrane body 6, and the upper notch 7 and the lower notch 8 are both located on the inner side of the outer wall of the ascending aorta 3 to avoid local wrinkles in the annular wrapping structure. Preferably, the first membrane body 5 and the second membrane body 6 are integrally formed by 3D printing. Because the ascending aorta 3 has a special shape, local wrinkles are prone to occur when the external support membrane 1 wraps the ascending aorta 3. If local wrinkles occur, the aortic wall will be compressed, affecting the aortic wall tissue, and easily causing physical damage, compression ischemia and other problems. The external stent membrane sheet 1 of the present invention is not a rectangular sheet, but is composed of a first membrane body 5 and a second membrane body 6 of the same structure, and an upper notch portion 7 and a lower notch portion 8 are provided between the first membrane body 5 and the second membrane body 6. The upper notch portion 7 and the lower notch portion 8 are both located on the inner side of the outer wall of the ascending aorta 3, so that the wrapping can well conform to the shape of the ascending aorta 3 and can fit well with the ascending aorta 3, avoiding the occurrence of local wrinkles in the annular wrapping structure.
其中,所述第一膜体5和第二膜体6相互远离的一侧均设有圆弧边,所述圆弧边的弯曲弧度与升主动脉3的外壁外侧弯曲弧度匹配,使得环状包裹结构能够更加贴合升主动脉3,且不会出现局部褶皱。为了便于使外支架膜片1收卷形成环状包裹结构,所述第一膜体5的圆弧边设有第一缝合带9,第二膜体6的圆弧边设有第二缝合带10,所述第一缝合带9和第二缝合带10相互缝合,以使第一膜体5和第二膜体6形成所述环状包裹结构。The first membrane body 5 and the second membrane body 6 are both provided with an arc edge on the side away from each other, and the curvature of the arc edge matches the curvature of the outer wall of the ascending aorta 3, so that the annular wrapping structure can fit the ascending aorta 3 better without local wrinkles. In order to facilitate the rolling of the external stent membrane 1 to form an annular wrapping structure, the arc edge of the first membrane body 5 is provided with a first suture belt 9, and the arc edge of the second membrane body 6 is provided with a second suture belt 10. The first suture belt 9 and the second suture belt 10 are sutured to each other, so that the first membrane body 5 and the second membrane body 6 form the annular wrapping structure.
如图1所示,在一种具体实施方式中,所述环状包裹结构与窦管交界处之间设有若干垫片11。优选地,所述环状包裹结构与窦管交界处之间设有多个垫片11,多个垫片11呈环状分布,且多个垫片11均通过缝合固定在外支架膜片1上。其中,所述外支架膜片1的底部设有下缝合带12,所述垫片11与下缝合带12连接。第一膜体5和第二膜体6的底部均设置下缝合带12,对垫片11进行固定。本发明的升主动脉外支架对升主动脉3采用整体性包裹,由于环状包裹结构的下端至少达到了窦管交界处的水平,甚至超越窦管交界处,且环状包裹结构与窦管交界处之间设置垫片11,这样的包裹加强了对主动脉窦和其内的主动脉瓣环的固定和环缩作用,增加对主动脉瓣环起到轻到中度的成型效果,有效减轻主动脉瓣反流的程度。As shown in FIG1 , in a specific embodiment, a plurality of gaskets 11 are provided between the annular wrapping structure and the junction of the sinus and tube. Preferably, a plurality of gaskets 11 are provided between the annular wrapping structure and the junction of the sinus and tube, the plurality of gaskets 11 are distributed in an annular shape, and the plurality of gaskets 11 are fixed on the outer support membrane 1 by suturing. Among them, a lower suture belt 12 is provided at the bottom of the outer support membrane 1, and the gasket 11 is connected to the lower suture belt 12. The bottom of the first membrane body 5 and the second membrane body 6 are both provided with a lower suture belt 12 to fix the gasket 11. The ascending aorta outer stent of the present invention wraps the ascending aorta 3 as a whole. Since the lower end of the annular wrapping structure at least reaches the level of the junction of the sinus and tube, or even exceeds the junction of the sinus and tube, and a gasket 11 is provided between the annular wrapping structure and the junction of the sinus and tube, such wrapping strengthens the fixation and ring contraction of the aortic sinus and the aortic valve ring therein, increases the mild to moderate molding effect on the aortic valve ring, and effectively reduces the degree of aortic valve regurgitation.
在一种具体实施方式中,所述外支架膜片1和分支膜片2均采用超高分子量聚乙烯材料制成,外支架膜片1和分支膜片2表面均设有网孔结构。外支架膜片1和分支膜片2均选超高分子量聚乙烯材料,这一材料在具有较高强度的同时,可以实现一定的柔软性,对主动脉壁的保护作用较强;外支架膜片1的网孔结构设计进一步减轻了外支架膜片1对升主动脉3的压迫,分支膜片2的网孔结构设计进一步减轻了分支膜片2对分支动脉4的压迫,降低了损伤。In a specific embodiment, the external stent diaphragm 1 and the branch diaphragm 2 are both made of ultra-high molecular weight polyethylene material, and the surface of the external stent diaphragm 1 and the branch diaphragm 2 are provided with a mesh structure. The external stent diaphragm 1 and the branch diaphragm 2 are both made of ultra-high molecular weight polyethylene material, which has a high strength and can achieve a certain degree of softness, and has a strong protective effect on the aortic wall; the mesh structure design of the external stent diaphragm 1 further reduces the pressure of the external stent diaphragm 1 on the ascending aorta 3, and the mesh structure design of the branch diaphragm 2 further reduces the pressure of the branch diaphragm 2 on the branch artery 4, reducing damage.
其中,所述分支膜片2的两端均与外支架膜片1缝合连接。优选地,所述外支架膜片1的顶部设有上缝合带13,分支膜片2的两端均与上缝合带13连接。第一膜体5和第二膜体6的顶部均设置上缝合带13,分支膜片2的一端固定于第一膜体5的上缝合带13,分支膜片2的另一端向上延伸,然后向下弯折形成悬吊部,使得分支膜片2的另一端固定于第二膜体6的上缝合带13,悬吊部挂在分支动脉4上,防止外支架膜片1发生位移。Wherein, both ends of the branch diaphragm 2 are sutured and connected to the external support diaphragm 1. Preferably, an upper suture belt 13 is provided on the top of the external support diaphragm 1, and both ends of the branch diaphragm 2 are connected to the upper suture belt 13. The upper suture belt 13 is provided on the top of the first membrane body 5 and the second membrane body 6, one end of the branch diaphragm 2 is fixed to the upper suture belt 13 of the first membrane body 5, and the other end of the branch diaphragm 2 extends upward and then bends downward to form a suspension part, so that the other end of the branch diaphragm 2 is fixed to the upper suture belt 13 of the second membrane body 6, and the suspension part is hung on the branch artery 4 to prevent the external support diaphragm 1 from displacement.
本发明提供了一种升主动脉外支架,其主要创新点包括:The present invention provides an ascending aorta external stent, the main innovative features of which include:
(1)升主动脉3的包裹与塑形:升主动脉外支架的结构形态使其能够很好地对升主动脉3进行塑形与包裹,与其功能相契合;外支架膜片1的形态考虑到了升主动脉3自身的形态特点,使得在包裹时外支架膜片1与血管能够很好地贴合;分支膜片2的设计使得外支架膜片1对于升主动脉3的远端同样能够起到很好的保护与支持作用;第一缝合带9和第二缝合带10的设计为外科缝合提供了空间,简化手术流程,增加缝合安全性;外支架膜片1下缘的下缝合带12为外支架膜片1近端与主动脉根部的固定提供了缝合区域。(1) Wrapping and shaping of the ascending aorta 3: The structural morphology of the ascending aorta external stent enables it to shape and wrap the ascending aorta 3 well, which is consistent with its function; the morphology of the external stent membrane 1 takes into account the morphological characteristics of the ascending aorta 3 itself, so that the external stent membrane 1 and the blood vessel can fit well when wrapping; the design of the branch membrane 2 enables the external stent membrane 1 to also play a good protective and supporting role for the distal end of the ascending aorta 3; the design of the first suture band 9 and the second suture band 10 provides space for surgical suture, simplifies the surgical process, and increases suture safety; the lower suture band 12 at the lower edge of the external stent membrane 1 provides a suture area for fixing the proximal end of the external stent membrane 1 to the aortic root.
(2)外支架膜片1的材料与网孔结构设计:外支架膜片1选用超高分子量聚乙烯,这一材料在具有较高强度的同时,可以实现一定的柔软性,对主动脉壁的保护作用较强;网孔结构的设计进一步减轻了对主动脉壁的压迫,降低了对升主动脉3的损伤。(2) Material and mesh structure design of the external stent membrane 1: The external stent membrane 1 is made of ultra-high molecular weight polyethylene, which has high strength and a certain degree of softness, and has a strong protective effect on the aortic wall; the mesh structure design further reduces the pressure on the aortic wall and reduces the damage to the ascending aorta 3.
(3)升主动脉3的整体性包裹理念:区别于传统单纯对升主动脉3包裹的方式,整体性包裹包括了:(a)从窦管交界处到动脉分支处的升主动脉3包裹;(b)在窦管交界处,外支架膜片1与主动脉管壁通过垫片11固定;(c)在升主动脉3远端及主动脉弓近端,分支膜片2对分支动脉4进行部分的包裹,从而起到支持与悬吊的作用;升主动脉3的整体性包裹策略能够使手术后的升主动脉3获得更优的形态及更好的远期效果,而该主动脉外支架的设计与这一理念相辅相成。(3) Holistic wrapping concept of the ascending aorta 3: Different from the traditional method of simply wrapping the ascending aorta 3, the holistic wrapping includes: (a) wrapping the ascending aorta 3 from the sinotubular junction to the arterial branch; (b) at the sinotubular junction, the external stent membrane 1 is fixed to the aortic wall by the gasket 11; (c) at the distal end of the ascending aorta 3 and the proximal end of the aortic arch, the branch membrane 2 partially wraps the branch artery 4, thereby playing a supporting and suspending role; the holistic wrapping strategy of the ascending aorta 3 can enable the ascending aorta 3 to obtain a better morphology and better long-term effect after surgery, and the design of the aortic external stent complements this concept.
(4)防局部褶皱设计:外支架膜片1并非矩形片状,而是由相同结构的第一膜体5和第二膜体6组成,且第一膜体5和第二膜体6之间具有上缺口部7和下缺口部8,上缺口部7和下缺口部8均位于升主动脉3的外壁内侧,这样包裹起来才能很好地符合升主动脉3的形态,并能很好地与升主动脉3贴合,避免环状包裹结构出现局部褶皱的情况。(4) Anti-local wrinkle design: The external stent membrane 1 is not a rectangular sheet, but is composed of a first membrane body 5 and a second membrane body 6 of the same structure, and an upper notch 7 and a lower notch 8 are provided between the first membrane body 5 and the second membrane body 6. The upper notch 7 and the lower notch 8 are both located on the inner side of the outer wall of the ascending aorta 3. In this way, the wrapping can well conform to the shape of the ascending aorta 3 and can fit well with the ascending aorta 3, thereby avoiding the occurrence of local wrinkles in the annular wrapping structure.
相对于现有的技术,本发明具有以下优点:Compared with the existing technology, the present invention has the following advantages:
(1)本发明免去了对升主动脉3的切除、切开等操作,完整保留了自身的升主动脉3,极大程度地降低了手术难度、手术创伤及风险。(1) The present invention eliminates the need for operations such as resection and incision of the ascending aorta 3, and completely preserves the ascending aorta 3, thereby greatly reducing the difficulty, trauma and risk of surgery.
(2)本发明不需要阻断升主动脉3,相关风险与创伤大大降低。(2) The present invention does not require blocking of the ascending aorta 3, and the related risks and trauma are greatly reduced.
(3)通过对由窦管交界处至主动脉弓近段的升主动脉3进行完整包裹,并且上端由分支膜片2包裹悬吊,消除了升主动脉瘤远期进展的风险,避免了升主动脉3两端进一步扩张形成“哑铃状”的可能;同时该处理方式能够有效避免环状包裹结构发生移位,提高升主动脉3的包裹效果。(3) By completely wrapping the ascending aorta 3 from the junction of the sinus tube to the proximal part of the aortic arch, and wrapping and suspending the upper end with the branch membrane 2, the risk of long-term progression of the ascending aortic aneurysm is eliminated, and the possibility of further expansion of the two ends of the ascending aorta 3 to form a "dumbbell shape" is avoided; at the same time, this treatment method can effectively prevent the displacement of the annular wrapping structure and improve the wrapping effect of the ascending aorta 3.
(4)外支架膜片1和分支膜片2均采用了超高分子量聚乙烯材料,设计有网孔结构,在保证塑形强度的同时具有一定的柔软性及伸缩性,且不对主动脉壁进行整体压迫,极大程度地保护了主动脉壁组织,降低了物理损伤、压迫缺血等问题。(4) Both the external stent membrane 1 and the branch membrane 2 are made of ultra-high molecular weight polyethylene material and are designed with a mesh structure. While ensuring the shaping strength, they have a certain degree of softness and elasticity, and do not compress the aortic wall as a whole, thus protecting the aortic wall tissue to a great extent and reducing problems such as physical damage, compression and ischemia.
(5)外支架膜片1的下端达到了窦管交界处的位置,这样的包裹实质上对主动脉窦和其内的主动脉瓣环起到了一定的固定和环缩作用,会对主动脉瓣环起到轻到中度的成型效果,对改善主动脉瓣结构与功能存在潜在作用。(5) The lower end of the external stent membrane 1 reaches the position of the sinus-tubular junction. Such wrapping actually plays a certain role in fixing and shrinking the aortic sinus and the aortic valve ring therein, and will have a light to moderate shaping effect on the aortic valve ring, which has a potential effect on improving the structure and function of the aortic valve.
在本发明描述中,术语“安装”、“相连”、“连接”、“固定”等应做广义理解,可以是固定连接,可拆卸连接,或成一体;可以是机械连接或电连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通或两个元件的相互作用关系,对本领域技术人员而言,可以理解上述术语在本发明中的具体含义。此外,实施例描述的具体特征、结构等包含于至少一种实施方式中,在不相互矛盾的情况下,本领域技术人员可以将不同实施方式的特征进行组合。本发明的保护范围并不局限于上述具体实施方式,根据本发明的基本技术构思,本领域普通技术人员无需经过创造性劳动,即可联想到的实施方式,均属于本发明的保护范围。In the description of the present invention, the terms "installed", "connected", "connected", "fixed" and the like should be understood in a broad sense, and may be fixedly connected, detachably connected, or integrated; may be mechanically connected or electrically connected; may be directly connected or indirectly connected through an intermediate medium, may be the internal connection of two elements or the interaction relationship between two elements. For those skilled in the art, the specific meanings of the above terms in the present invention can be understood. In addition, the specific features, structures, etc. described in the embodiments are included in at least one embodiment. Under the condition that there is no contradiction, those skilled in the art may combine the features of different embodiments. The protection scope of the present invention is not limited to the above-mentioned specific embodiments. According to the basic technical concept of the present invention, the embodiments that can be associated with by ordinary technicians in this field without creative work all belong to the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410752795.5A CN118453215A (en) | 2024-06-12 | 2024-06-12 | Ascending aorta external support |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410752795.5A CN118453215A (en) | 2024-06-12 | 2024-06-12 | Ascending aorta external support |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118453215A true CN118453215A (en) | 2024-08-09 |
Family
ID=92170623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410752795.5A Pending CN118453215A (en) | 2024-06-12 | 2024-06-12 | Ascending aorta external support |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118453215A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060129228A1 (en) * | 2002-09-19 | 2006-06-15 | Golesworthy Taliesin J | Stents |
US20060178726A1 (en) * | 2004-10-25 | 2006-08-10 | Myles Douglas | Vascular graft and deployment system |
US20100070019A1 (en) * | 2006-10-29 | 2010-03-18 | Aneuwrap Ltd. | extra-vascular wrapping for treating aneurysmatic aorta and methods thereof |
CN102227190A (en) * | 2008-09-26 | 2011-10-26 | 血管动力学公司 | Devices and methods for control of blood pressure |
US20130218191A1 (en) * | 2010-04-26 | 2013-08-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
US20130226280A1 (en) * | 2011-08-29 | 2013-08-29 | Aortic Wrap Pty Ltd | Method and Device For Treating a Stiffened Blood Vessel |
CN116919654A (en) * | 2023-07-06 | 2023-10-24 | 首都医科大学附属北京安贞医院 | Artificial blood vessel for wrapping aortic or branch lesion thereof |
-
2024
- 2024-06-12 CN CN202410752795.5A patent/CN118453215A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060129228A1 (en) * | 2002-09-19 | 2006-06-15 | Golesworthy Taliesin J | Stents |
US20060178726A1 (en) * | 2004-10-25 | 2006-08-10 | Myles Douglas | Vascular graft and deployment system |
US20100070019A1 (en) * | 2006-10-29 | 2010-03-18 | Aneuwrap Ltd. | extra-vascular wrapping for treating aneurysmatic aorta and methods thereof |
CN102227190A (en) * | 2008-09-26 | 2011-10-26 | 血管动力学公司 | Devices and methods for control of blood pressure |
US20130218191A1 (en) * | 2010-04-26 | 2013-08-22 | Paul Heltai | Method for deploying a sleeve and tubing device for restricting and constricting aneurysms and a sleeve and tubing device and system |
US20130226280A1 (en) * | 2011-08-29 | 2013-08-29 | Aortic Wrap Pty Ltd | Method and Device For Treating a Stiffened Blood Vessel |
CN116919654A (en) * | 2023-07-06 | 2023-10-24 | 首都医科大学附属北京安贞医院 | Artificial blood vessel for wrapping aortic or branch lesion thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SVENSSON | Rationale and technique for replacement of the ascending aorta, arch, and distal aorta using a modified elephant trunk procedure | |
CN106726001B (en) | Suture-free stent artificial blood vessel and its delivery device, anastomotic buckle | |
US6539945B2 (en) | Minimally invasive cardiac surgery procedure | |
CN101057796A (en) | Lung arterial support with valve | |
CN102462565A (en) | Recoverable adjustable interventional stent for constriction in blood vessel | |
JP2005505319A (en) | Positioning assembly and method of use | |
JP2003517330A (en) | Apparatus and method for anterior segment coronary artery restoration | |
CN101444441A (en) | Support type artificial venous blood vessel with valve | |
Marven et al. | Contemporary postnatal surgical management strategies for congenital abdominal wall defects | |
CN109833112A (en) | Bracket and its application method in a kind of art | |
CN107789094A (en) | Exempt to suture stent-graft, superlastic braiding retainer ring | |
CN108403255A (en) | A kind of novel bow portion stent system and its application method | |
CN101081181A (en) | Device for treating congenital herat disease and using method thereof | |
CN201333110Y (en) | Regulable double branch artificial aortic arch prosthesis | |
CN104161605A (en) | Improved support artificial blood vessel | |
CN118453215A (en) | Ascending aorta external support | |
RU2477082C1 (en) | Method of surgical correction of aorta coarctation in children of young age | |
CN209450719U (en) | Overlay film frame | |
RU2728702C1 (en) | Method for simultaneous ascending aorta prosthetics and arch exoprosthesis | |
Bailey et al. | The surgical treatment of aortic insufficiency | |
WO2023241702A1 (en) | Use of biological material in preparing product for limiting gastric volume | |
CN118512292A (en) | Manufacturing method of ascending aorta external stent | |
CN204636630U (en) | A kind of outflow tract of right ventricle support embedded device | |
CN208838245U (en) | Exempt to suture stent-graft, superlastic braiding fixed ring | |
CN221786842U (en) | Aortic root shaping device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |